Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr 28:8:85.
doi: 10.1186/1475-2875-8-85.

A retrospective analysis of the change in anti-malarial treatment policy: Peru

Affiliations
Review

A retrospective analysis of the change in anti-malarial treatment policy: Peru

Holly Ann Williams et al. Malar J. .

Abstract

Background: National malaria control programmes must deal with the complex process of changing national malaria treatment guidelines, often without guidance on the process of change. Selecting a replacement drug is only one issue in this process. There is a paucity of literature describing successful malaria treatment policy changes to help guide control programs through this process.

Objectives: To understand the wider context in which national malaria treatment guidelines were formulated in a specific country (Peru).

Methods: Using qualitative methods (individual and focus group interviews, stakeholder analysis and a review of documents), a retrospective analysis of the process of change in Peru's anti-malarial treatment policy from the early 1990's to 2003 was completed.

Results: The decision to change Peru's policies resulted from increasing levels of anti-malarial drug resistance, as well as complaints from providers that the drugs were no longer working. The context of the change occurred in a time in which Peru was changing national governments, which created extreme challenges in moving the change process forward. Peru utilized a number of key strategies successfully to ensure that policy change would occur. This included a) having the process directed by a group who shared a common interest in malaria and who had long-established social and professional networks among themselves, b) engaging in collaborative teamwork among nationals and between nationals and international collaborators, c) respect for and inclusion of district-level staff in all phases of the process, d) reliance on high levels of technical and scientific knowledge, e) use of standardized protocols to collect data, and f) transparency.

Conclusion: Although not perfectly or fully implemented by 2003, the change in malaria treatment policy in Peru occurred very quickly, as compared to other countries. They identified a problem, collected the data necessary to justify the change, utilized political will to their favor, approved the policy, and moved to improve malaria control in their country. As such, they offer an excellent example for other countries as they contemplate or embark on policy changes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key events in changing Peru's anti-malarial drug policy.

References

    1. World Health Organization . A Global Strategy for Malaria Control. Geneva: World Health Organization; 1993.
    1. Williams HA, Durrheim D, Shretta R. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004;19:356–370. doi: 10.1093/heapol/czh051. - DOI - PubMed
    1. Mubyazi G, Gonzalez-Block M. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J. 2005;4:51. doi: 10.1186/1475-2875-4-51. - DOI - PMC - PubMed
    1. Mulligan JA, Mandike R, Palmer N, Williams H, Abdulla S, Bloland P, Mills A. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. Trop Med Int Health. 2006;11:452–461. doi: 10.1111/j.1365-3156.2006.01590.x. - DOI - PubMed
    1. Sipilanyambe N, Simon J, Chanda P, Olumese P, Snow R, Hamer D. From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Malar J. 2008;7:25. doi: 10.1186/1475-2875-7-25. - DOI - PMC - PubMed

Publication types